James Thomson, the UW-Madison biologist whose stem cell discovery 20 years ago opened fascinating and promising new avenues in science, took time to discuss his thoughts on the breakthrough and what the future holds for the field of regenerative medicine.
An international conference held in Madison last April offered an enticing glimpse into the future of stem cell therapies. Organized by UW-Madison stem cell pioneer James Thomson, the event showcased human clinical trials under way for cellular therapies to treat Parkinson’s disease, macular degeneration, heart failure, diabetes and spinal cord injury.
An interest in endangered species led scientist James Thomson to make one of the world’s most profound scientific discoveries. In 1998, for the first time, Thomson successfully cultured human embryonic stem cells, which are pluripotent – capable of becoming nearly any of the 200 different cells types in the body.
The stem cell discovery at UW-Madison in 1998 ushered in a new era of science. Today, researchers there continue their quest to find treatments and cures. Here’s a look at the cellular wonders of stem cell research.
On Nov. 6, 1998, developmental biologist James Thomson of the University of Wisconsin–Madison published a paper describing how his team had grown human embryonic stem cells. These cells exist at the earliest stages of development and are “pluripotent” — able to differentiate into every one of the more than 200 specialized cell types in the human body.
Randolph Ashton, assistant professor of biomedical engineering, is the new associate director for UW–Madison’s Stem Cell and Regenerative Medicine Center. He joins Timothy Kamp, center director and professor of medicine, cell and regenerative biology, and succeeds William Murphy, professor …
November 2018 marks the 20th anniversary of the seminal human embryonic stem cell (hESC) publication, which reported the initial hESC derivations and launched the field of human pluripotent stem cell research. To commemorate this significant milestone, we reflect on the scientific, economic, and clinically relevant impact of this groundbreaking achievement.
In November 1998, the world was introduced to human embryonic stem cells, the blank slate cells that arise at the earliest stages of development and that go on to become any of the scores of cell types that make up a human.
When Kaivalya Molugu was considering graduate schools, she knew she was interested in stem cell research, but she had to decide where to apply. The answer soon became clear: the place where it all began. One of the main reasons she chose UW–Madison “is the strong stem cell research center here,” says Molugu, a biophysics research assistant at the Wisconsin Institute for Discovery and a trainee with the UW’s Stem Cell and Regenerative Medicine Center (SCRMC).